Inhibition of plasminogen/plasmin system retrieves endogenous nerve growth factor and adaptive spinal synaptic plasticity following peripheral nerve injury

Neurochem Int. 2021 Sep:148:105113. doi: 10.1016/j.neuint.2021.105113. Epub 2021 Jun 23.

Abstract

Dysfunctions of the neuronal-glial crosstalk and/or impaired signaling of neurotrophic factors represent key features of the maladaptive changes in the central nervous system (CNS) in neuroinflammatory as neurodegenerative disorders. Tissue plasminogen activator (tPA)/plasminogen (PA)/plasmin system has been involved in either process of maturation and degradation of nerve growth factor (NGF), highlighting multiple potential targets for new therapeutic strategies. We here investigated the role of intrathecal (i.t.) delivery of neuroserpin (NS), an endogenous inhibitor of plasminogen activators, on neuropathic behavior and maladaptive synaptic plasticity in the rat spinal cord following spared nerve injury (SNI) of the sciatic nerve. We demonstrated that SNI reduced spinal NGF expression, induced spinal reactive gliosis, altering the expression of glial and neuronal glutamate and GABA transporters, reduced glutathione (GSH) levels and is associated to neuropathic behavior. Beside the increase of NGF expression, i.t. NS administration reduced reactive gliosis, restored synaptic homeostasis, GSH levels and reduced neuropathic behavior. Our results hereby highlight the essential role of tPA/PA system in the synaptic homeostasis and mechanisms of maladaptive plasticity, sustaining the beneficial effects of NGF-based approach in neurological disorders.

Keywords: Maladaptive synaptic plasticity; NGF; Nerve injury; Reactive gliosis; Spinal cord; Synaptic homeostasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal
  • Fibrinolysin / antagonists & inhibitors*
  • Gliosis
  • Injections, Spinal
  • Male
  • Nerve Growth Factors / metabolism*
  • Neuralgia / psychology
  • Neuronal Plasticity*
  • Neuropeptides / administration & dosage
  • Neuropeptides / therapeutic use
  • Neuroserpin
  • Peripheral Nerve Injuries / metabolism*
  • Peripheral Nerve Injuries / physiopathology*
  • Peripheral Nerve Injuries / psychology
  • Plasminogen / antagonists & inhibitors*
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function
  • Sciatic Nerve / injuries
  • Serpins / administration & dosage
  • Serpins / therapeutic use
  • Spinal Cord / physiopathology*

Substances

  • Nerve Growth Factors
  • Neuropeptides
  • Serpins
  • Plasminogen
  • Fibrinolysin